Written by: Jacky Lee
Thursday 28 May 2015
IPO watch - Singapore O&G Ltd
New healthcare play in growing market
The IPO price of S$0.25 translates to 13x FY14 historical PER and 4.5x PBR which seems attractive for a healthcare play. Given its zero debt and high cash flow generation with potential 7-8% dividend yield projected, we recommend to ...
This article requires a premium subscription. Click
If you are not yet a registered member of NetResearch Asia, please click
here to register before paying.
If you accessing this site though Lim&Tan's website and using
Internet Explorer, please click
to rectify access issues.
Access to this Web site is granted by NRA Capital Pte. Ltd. strictly on the terms
and subject to the conditions set out hereunder. By entering into the Web Site,
Subscriber is deemed to have accepted and agreed to be bound by the
terms and conditions
set out hereunder.